China Life Private Equity Investment logo

China Life Private Equity Investment

Asia, Beijing, China, Beijing

Description

China Life Private Equity Investment is a equity investment platform.

Investor Profile

China Life Private Equity Investment has made 5 investments, with 1 in the past 12 months and 40% as lead.

Stage Focus

  • Series B (60%)
  • Series C (20%)
  • Series Unknown (20%)

Country Focus

  • China (100%)

Industry Focus

  • Industrial
  • Manufacturing
  • Biotechnology
  • Biopharma
  • Pharmaceutical
  • Energy
  • Solar
  • Health Care
  • Oncology
  • Semiconductor
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does China Life Private Equity Investment frequently co-invest with?

CICC
Asia, Beijing, China, Beijing
Co-Investments: 1
Yangtze River Industry Fund
Asia, Hubei, China, Wuhan
Co-Investments: 1
Guangzhou Yuexiu Industrial Investment Fund
Asia, Guangdong, China, Guangzhou
Co-Investments: 1
China Capital Management
Asia, Beijing, China, Beijing
Co-Investments: 1
Co-Investments: 1
Hillhouse Investment
Asia, Central Region, Singapore, Singapore
Co-Investments: 1
SI
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Co-Investments: 1
Zhaoxi Capital
Asia, Shanghai, China, Shanghai
Co-Investments: 1
BOCOM International
Asia, Hong Kong Island, Hong Kong, Central
Co-Investments: 1
Walden International
North America, California, United States, San Francisco
Co-Investments: 1

What are some of recent deals done by China Life Private Equity Investment?

SJ Semi

Jiangyin, Jiangsu, China

SJ Semi is a MEOL (Middle-End of Line) foundry that implements front-end wafer manufacturing and quality systems for MEOL operations.

IndustrialManufacturingSemiconductor
Series UnknownDec 31, 2024
Amount Raised: $700,000,000
Astronergy

Hangzhou, Zhejiang, China

Astronergy specializes in the research, development, and production of solar modules.

EnergyIndustrialManufacturingSolar
Series CJul 25, 2023
Amount Raised: $280,257,276
Yingke Biopharmaceutical

Taizhou, Jiangsu, China

Yingke Biopharmaceutical operates as a high-tech biopharmaceutical enterprise integrating R&D, production and sales.

BiopharmaPharmaceutical
Series BJun 1, 2023
Amount Raised: $42,286,278
MAXVAX

Shuangliu, Sichuan, China

MAXVAX aims to provide novel vaccine development and commercialization.

BiotechnologyHealth Care
Series BJul 22, 2022
Amount Raised: $74,059,811
Harbour Biomed

Shanghai, Shanghai, China

Harbour BioMed is a clinical stage biopharmaceutical company developing innovative therapeutics in the fields of immuno-oncology.

BiopharmaBiotechnologyOncologyPharmaceutical
Series BAug 27, 2018
Amount Raised: $85,000,000